TheAbC-19 rapid antibody test is an immunological test forCOVID-19 exposure developed by theUK Rapid Test Consortium and manufactured byAbingdon Health. It uses alateral flow test to determine whether a person hasIgG antibodies to theSARS-CoV-2 virus that causes COVID-19. The test uses a single drop of blood obtained from a finger prick and yields results in 20 minutes. The sensitivity of this test is 98.03% while the specificity is 99.56%.[1] This test is paired with an easy-to-use mobile app which allows a trained professional to generate an antibody test certificate for storing on a person's smartphone.[1][2]
Thisimmunology article is astub. You can help Wikipedia byexpanding it. |
ThisUnited Kingdom-related article is astub. You can help Wikipedia byexpanding it. |
This article about theCOVID-19 pandemic is astub. You can help Wikipedia byexpanding it. |